中国的DNA定序市场

预计在预测期（2025-2030 年），中国 DNA定序市场规模将以 21.5% 的复合年增长率扩大，从 2025 年的 12 亿美元增至 2030 年底的 31 亿美元。

中国 DNA定序市场的次世代定序(NGS) 部分预计在预测期 (2025-2030 年) 的复合年增长率将达到 22.1%，从 2025 年的 8.926 亿美元增长到 2030 年底的 24 亿美元。

中国 DNA定序市场的第三代定序部分预计在预测期内（2025-2030 年）将以 21.7% 的复合年增长率扩大，从 2025 年的 1.62 亿美元增至 2030 年底的 4.32 亿美元。

调查范围

本报告概况了中国DNA定序市场并分析了市场趋势。报告收益（百万美元）和2025年的预估数据，以及截至2030年底的年复合成长率（CAGR）预测。市场分析涵盖产品/服务、技术、应用、最终用户和地区。本研究涵盖的地区包括北京、上海、广东等。

本报告中的「中国」指中国当地，不包括香港、澳门及台湾。中国当地共有31个省级行政区，包括22个省、4个省级市和5个省级自治区。本报告也涵盖了北京市、上海市和广东省。

该报告还重点介绍了创业投资和企业投资发展、监管趋势、主要参与者的企业策略，以及人工智慧定序在精准医疗和群体基因组学计画中衍生的潜在未来机会。报告结合了深入的市场预测、宏观经济分析和海关评估，使其成为相关人员、投资者和政策制定者了解和利用中国快速发展的DNA定序行业的重要资源。报告重点关注影响市场和供应商格局的关键驱动趋势和挑战，并分析了与市场相关的新兴技术。

报告最后进行了竞争格局分析，提供了主要企业的排名和市场份额，还包括一个专门的公司简介部分，其中包含主要企业的详细资讯。

报告内容

• 16 个资料表和 40 个附加表
• 中国DNA测序技术市场概况及分析
• 中国市场趋势分析，包括 2022 年至 2024 年的收益数据、2025 年的估计值以及 2030 年的复合年增长率预测
• 市场规模和收益估算，按产品/服务类型、技术、应用、最终用户和地区进行市场份额分析
• 有关市场动态、机会和阻碍因素、技术进步、法规和宏观经济变数影响的事实和数据
• 波特五力模型与全球供应链分析的见解
• 下一代DNA测序技术及其在研究和临床市场应用的新兴趋势和机会研究
• 产业结构分析，包括公司市场份额和排名、策略联盟、併购活动和创业融资前景
• 华大基因、诺禾致源、贝瑞基因、安诺优达基因、燃石医学等

目录

第一章执行摘要

第二章 市场概况

• 概述和市场定义
• 波特五力分析
• 美国关税的影响
• 对全球公司（例如 Illumina、Thermo Fisher Scientific）的直接影响
• 间接影响：促进中国国内成长与自给自足
• 市场结构及其对长期趋势的影响

第三章 市场动态

• 市场动态
• 市场驱动因素
• 政府投资和国家战略倡议
• 创新与技术进步－让定序变得经济实惠
• 精准医疗和肿瘤基因组学的需求不断增长
• 市场限制
• DNA测序技术高成本且操作障碍
• 监管复杂性和资料隐私挑战
• 市场机会
• 扩大精准医疗
• 扩大非侵入性产前检测

第四章：监理现状

• 中国DNA定序产业监管现状
• 主要监管机构
• 人类遗传资源（HGR）条例
• DNA定序的临床应用

第五章 新兴科技与发展

• 新兴技术
• 长读定序技术
• 单分子即时（SMRT）定序
• 奈米孔定序
• 空间基因组学和转录组学
• 单细胞DNA定序
• 超低输入定序
• CRISPR-Cas9、基因组编辑和定序技术的整合
• DNA定序中的人工智慧（AI）和机器学习

第六章市场区隔分析

• 细分市场
• 中国DNA定序市场分析（依产品/服务）
• 设备和耗材
• 服务
• 中国DNA定序市场分析（依技术）
• 次世代定序（NGS）
• 第三代定序
• 桑格定序
• 焦磷酸测序
• 中国DNA定序市场分析（依应用）
• 生物製药
• 微生物学
• 农业
• 中国DNA定序市场分析（依最终用户）
• 学术研究机构
• 医院和诊所
• 製药和生物技术公司
• 临床研究
• 中国DNA定序市场分析（分省）
• 广东省
• 北京
• 上海
• 其他区域市场

第七章 竞争态势

• 概述
• 国内公司
• 国际公司

第八章 附录

• 调查方法
• 参考
• 简称
• 公司简介
• AGILENT TECHNOLOGIES INC.
• ANNOROAD GENE TECHNOLOGY
• BERRY GENOMICS
• BGI
• BURNING ROCK DX
• CAPITALBIO TECHNOLOGY CO. LTD.
• ILLUMINA INC.
• NOVOGENE CO. LTD.
• OXFORD NANOPORE TECHNOLOGIES PLC
• PACBIO
• THERMO FISHER SCIENTIFIC INC.
• 新兴Start-Ups/市场颠覆者

The Chinese DNA sequencing market is expected to grow from $1.2 billion in 2025 and is projected to reach $3.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 21.5% during the forecast period of 2025 to 2030.

The Next-generation sequencing (NGS) segment of Chinese DNA sequencing market is expected to grow from $892.6 million in 2025 and is projected to reach $2.4 billion by the end of 2030, at a CAGR of 22.1% during the forecast period of 2025 to 2030.

The third-generation sequencing segment of Chinese DNA sequencing market is expected to grow from $162 million in 2025 and is projected to reach $432 million by the end of 2030, at a CAGR of 21.7% during the forecast period of 2025 to 2030.

Report Scope

This report provides an overview of the Chinese market for DNA sequencing and analyzes market trends. It includes revenue ($ million) for the base year data for 2024 and estimated data for 2025, and compound annual growth rate (CAGR) forecasts through the end of 2030. The market analyzed by products and services, technology, applications, end-users and provinces. The provinces covered in this study include Beijing, Shanghai, Guangdong and others.

In this report, "China" refers to mainland China and does not include Hong Kong, Macao, or Taiwan. Mainland China has 31 province-level regions, including 22 provinces, four province-level municipalities (cities) and five province-level autonomous regions. Beijing, Shanghai and Guangdong are also discussed in this report.

The report also highlights developments related to venture capital and corporate investments, regulatory trends and enterprise strategies of key firms and potential future opportunities stemming from AI-driven sequences of precision medicine and population genomics programs. The combination of in-depth market forecasts, macroeconomic analysis and tariff assessments makes this report a critical resource for stakeholders, investors and policymakers seeking to understand and take advantage of the rapidly developing Chinese DNA sequencing sector. The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It also analyzes emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape, which provides the ranking or share of key companies. It also has a dedicated section of company profiles that covers details of leading companies.

Report Includes

• 16 data tables and 40 additional tables
• Overview and an analysis of the Chinese market for DNA sequencing technologies
• Analyses of the Chinese market trends, with revenue data from 2022-2024, estimates for 2025, and projected CAGRs through 2030
• Estimates of the size and revenue prospects for the market, along with a market share analysis by product and service type, technology, application, end user and provinces
• Facts and figures pertaining to market dynamics, opportunities and deterrents, technological advances, regulations and the impacts of macroeconomic variables
• Insights derived from Porter's Five Forces model and global supply chain analysis
• Discussion of emerging trends and opportunities in next-generation DNA sequencing technologies and applications in research and clinical markets
• Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
• Profiles of the leading companies, including BGI, Novogene Co. Ltd., Berry Genomics, Annoroad Gene Technology, and Burning Rock Dx.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Technological Advances
• Market Dynamics and Growth Factors
• Segmental Analysis
• Conclusion

Chapter 2 Market Overview

• Overview and Market Definition
• Porter's Five Forces Analysis
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Potential for New Entrants
• Competition in the Industry
• Threat of Substitutes
• Impact of the U.S. Tariffs
• Direct Impact on Global Companies (e.g., Illumina, Thermo Fisher Scientific)
• Indirect Impact: Catalyzing Domestic Growth and Self-Sufficiency in China
• Impact on Market Structure and Long-Term Dynamics

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Government Investment and National Strategic Initiatives
• Innovation and Technological Advances - Making Sequencing Affordable
• Growing Demand for Precision Medicine and Oncology Genomics
• Market Restraints
• High Cost of DNA Sequencing Technologies and Operational Barriers
• Regulatory Complexity and Data Privacy Challenges
• Market Opportunities
• Expansion of Precision Medicine
• Growth in Non-invasive Prenatal Testing

Chapter 4 Regulatory Landscape

• Chinese DNA Sequencing Industry Regulatory Scenario
• Key Regulatory Authorities
• Human Genetic Resources (HGR) Regulations
• Clinical Use of DNA Sequencing

Chapter 5 Emerging Technologies and Developments

• Emerging Technologies
• Long-Read Sequencing Technologies
• Single-Molecule Real-Time (SMRT) Sequencing
• Nanopore Sequencing
• Spatial Genomics and Transcriptomics
• Single-Cell DNA Sequencing
• Ultra-Low-Input Sequencing
• CRISPR-Cas9 and Genome Editing Integration with Sequencing Technologies
• Artificial Intelligence (AI) and Machine Learning in DNA Sequencing

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Chinese DNA Sequencing Market Analysis by Product and Service
• Instruments and Consumables
• Services
• Chinese DNA Sequencing Market Analysis, by Technology
• Next-Generation Sequencing (NGS)
• Third-Generation Sequencing
• Sanger Sequencing
• Pyrosequencing
• Chinese DNA Sequencing Market Analysis, by Application
• Biopharma
• Microbiology
• Agriculture
• Chinese DNA Sequencing Market Analysis, by End User
• Academic and Research Institutes
• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Clinical Research
• Chinese DNA Sequencing Market Analysis, by Province
• Guangdong
• Beijing
• Shanghai
• Other Chinese Regional Markets

Chapter 7 Competitive Landscape

• Overview
• Domestic Companies
• International Companies

Chapter 8 Appendix

• Methodology
• References
• Abbreviations
• Company Profiles
• AGILENT TECHNOLOGIES INC.
• ANNOROAD GENE TECHNOLOGY
• BERRY GENOMICS
• BGI
• BURNING ROCK DX
• CAPITALBIO TECHNOLOGY CO. LTD.
• ILLUMINA INC.
• NOVOGENE CO. LTD.
• OXFORD NANOPORE TECHNOLOGIES PLC
• PACBIO
• THERMO FISHER SCIENTIFIC INC.
• Emerging Start-ups/Market Disruptors

List of Tables

• Summary Table : Chinese Market for DNA Sequencing, by Technology, Through 2030
• Table 1 : Chinese Market for DNA Sequencing, by Product and Service, Through 2030
• Table 2 : DNA Sequencing Instruments and Consumables Offered by Major Companies
• Table 3 : Chinese Market for DNA Sequencing Instruments and Consumables, by Workflow, Through 2030
• Table 4 : Chinese Market for DNA Sequencing Services, by Workflow, Through 2030
• Table 5 : Chinese Market for DNA Sequencing, by Technology, Through 2030
• Table 6 : Chinese Market for DNA Sequencing, by Application, Through 2030
• Table 7 : Chinese Market for DNA Sequencing, by End User, Through 2030
• Table 8 : Chinese Market for DNA Sequencing, by Province, Through 2030
• Table 9 : Leading Chinese DNA Sequencing Companies, 2024
• Table 10 : Leading Chinese DNA Sequencing Companies' Strategic Developments, 2023-2025
• Table 11 : Information Sources for this Report
• Table 12 : Glossary of Terms Used in the Chinese DNA Sequencing Market
• Table 13 : Agilent Technologies Inc.: Company Snapshot
• Table 14 : Agilent Technologies Inc.: Financial Performance, FY 2023 and 2024
• Table 15 : Agilent Technologies Inc.: Product Portfolio
• Table 16 : Agilent Technologies Inc.: News/Key Developments, 2023-2024
• Table 17 : Annoroad Gene Technology: Company Snapshot
• Table 18 : Annoroad Gene Technology: Product Portfolio
• Table 19 : Annoroad Gene Technology: News/Key Developments, 2024
• Table 20 : Berry Genomics: Company Snapshot
• Table 21 : Berry Genomics: Financial Performance, FY 2023 and 2024
• Table 22 : Berry Genomics: Product Portfolio
• Table 23 : Berry Genomics: News/Key Developments, 2024-2025
• Table 24 : BGI: Company Snapshot
• Table 25 : BGI: Financial Performance, FY 2023 and 2024
• Table 26 : BGI: Product Portfolio
• Table 27 : BGI: News/Key Developments, 2025
• Table 28 : Burning Rock Dx: Company Snapshot
• Table 29 : Burning Rock Dx: Financial Performance, FY 2022 and 2023
• Table 30 : Burning Rock Dx: Product Portfolio
• Table 31 : Burning Rock Dx: News/Key Developments, 2023-2024
• Table 32 : CapitalBio Technology Co. Ltd.: Company Snapshot
• Table 33 : CapitalBio Technology Co. Ltd.: Product Portfolio
• Table 34 : CapitalBio Technology Co. Ltd.: News/Key Developments, 2024-2025
• Table 35 : Illumina Inc.: Company Snapshot
• Table 36 : Illumina Inc.: Financial Performance, FY 2023 and 2024
• Table 37 : Illumina Inc.: Product Portfolio
• Table 38 : Illumina Inc.: News/Key Developments, 2023-2024
• Table 39 : Novogene Co. Ltd.: Company Snapshot
• Table 40 : Novogene Co. Ltd.: Financial Performance, FY 2023 and 2024
• Table 41 : Novogene Co. Ltd.: Product Portfolio
• Table 42 : Novogene Co. Ltd.: News/Key Developments, 2023-2024
• Table 43 : Oxford Nanopore Technologies plc: Company Snapshot
• Table 44 : Oxford Nanopore Technologies plc: Financial Performance, FY 2023 and 2024
• Table 45 : Oxford Nanopore Technologies plc: Product Portfolio
• Table 46 : Oxford Nanopore Technologies plc: News/Key Developments, 2024
• Table 47 : PacBio: Company Snapshot
• Table 48 : PacBio: Financial Performance, FY 2023 and 2024
• Table 49 : PacBio: Product Portfolio
• Table 50 : PacBio: News/Key Developments, 2023-2024
• Table 51 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 52 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
• Table 53 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 54 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023-2025
• Table 55 : List of Few Emerging Startups in the Chinese market for DNA sequencing

List of Figures

• Summary Figure : Chinese Market Shares of DNA Sequencing, by Technology, 2024
• Figure 1 : Porter's Five Forces Analysis of the Chinese DNA Sequencing Market
• Figure 2 : Market Dynamics Snapshot of Chinese DNA Sequencing
• Figure 3 : Chinese Market Shares of DNA Sequencing, by Product and Service, 2024
• Figure 4 : Chinese Market Shares of DNA Sequencing, by Technology, 2024
• Figure 5 : Different NGS Technologies and Their Applications
• Figure 6 : Chinese Market Shares of DNA Sequencing, by Application, 2024
• Figure 7 : Chinese Market Shares of DNA Sequencing, by End User, 2024
• Figure 8 : Chinese Market Shares of DNA Sequencing, by Province, 2024
• Figure 9 : Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2024
• Figure 10 : Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2024
• Figure 11 : BGI: Revenue Shares, by Business Unit, FY 2024
• Figure 12 : BGI: Revenue Shares, by Country/Region, FY 2024
• Figure 13 : Burning Rock Dx: Revenue Shares, by Business Segment, FY 2024
• Figure 14 : Burning Rock Dx: Revenue Shares, by Country/Region, FY 2024
• Figure 15 : Illumina Inc.: Revenue Shares, by Business Unit, FY 2024
• Figure 16 : Illumina Inc.: Revenue Shares, by Country/Region, FY 2024
• Figure 17 : Oxford Nanopore Technologies plc: Revenue Shares, by Country/Region, FY 2024
• Figure 18 : PACBIO: Revenue Shares, by Business Unit, FY 2024
• Figure 19 : PACBIO: Revenue Shares, by Country/Region, FY 2024
• Figure 20 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2024
• Figure 21 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2024